Clinical Trial Update: Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update for ADSTEM Injection to treat moderate to severe subacute and chronic atopic dermatitis; the study is currently not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ADSTEM Injection

Snippet

Sponsor: EHL Bio Co., Ltd. | Conditions: Atopic Dermatitis | Phase 3 | Status: NOT_YET_RECRUITING